AVTX · Avalo Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| ARMISTICE CAPITAL, LLC Director | ▼ Sell | Open Market | 731,458 Shares held | 6/27/2023 | View profile |
| NEIL GARRY ARTHUR Chief Scientific Officer | ▲ Buy | Grant | 190,314 Shares held | 5/21/2026 | View profile |
| Doyle Mittie Chief Medical Officer | ▼ Sell | Open Market | 51,776 Shares held | 8/28/2026 | View profile |
| Sullivan Christopher Ryan Chief Financial Officer | ▼ Sell | Open Market | 39,900 Shares held | 9/16/2026 | View profile |
| Riley Jennifer Chief Strategy Officer | ▼ Sell | Open Market | 37,041 Shares held | 8/11/2026 | View profile |
| Harrell James Archie Jr Chief Commercial Officer | ▲ Buy | Open Market | 36,766 Shares held | 12/10/2021 | View profile |
| Wilkins H Jeffrey Chief Medical Officer | ▲ Buy | Open Market | 33,373 Shares held | 12/10/2021 | View profile |
| VARKI PAUL Chief Legal Officer | ▼ Sell | Tax Withholding | 32,576 Shares held | 6/10/2026 | View profile |
| KAPLAN GILLA Director | ▲ Buy | Option Exercise | 6,333 Shares held | 3/28/2026 | View profile |
| Truex Samantha Director | ▲ Buy | Option Exercise | 6,333 Shares held | 3/28/2026 | View profile |
| KANTOFF AARON Director | ▲ Buy | Option Exercise | 6,333 Shares held | 3/28/2026 | View profile |
| Greenway Schond L. CFO | ▲ Buy | Open Market | 3,883 Shares held | 12/10/2021 | View profile |
| Almenoff June Sherie Director | ▲ Buy | Option Exercise | 3,167 Shares held | 3/28/2025 | View profile |
| Mitchell Chan Chief Financial Officer | ▼ Sell | Open Market | 3,166 Shares held | 5/6/2026 | View profile |
| Goldman Jonathan Director | ▲ Buy | Option Exercise | 3,166 Shares held | 3/28/2026 | View profile |
| Caissa Capital Management ltd. 10% Owner | ▲ Buy | Open Market | 0 Shares held | 6/26/2023 | View profile |
Transaction History
| Sullivan Christopher Ryan | ▲ Buy | Option Exercise | 12,394 | $122K | 9/16/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 12,394 | $202K | 9/16/2026 |
| Sullivan Christopher Ryan | ▲ Buy | Option Exercise | 10,185 | $82K | 9/10/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 10,185 | $179K | 9/10/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 679 | $5K | 8/28/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 679 | $14K | 8/28/2026 |
| Sullivan Christopher Ryan | ▲ Buy | Option Exercise | 31,031 | $307K | 8/18/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 31,031 | $622K | 8/18/2026 |
| Sullivan Christopher Ryan | ▲ Buy | Option Exercise | 37,945 | $375K | 8/17/2026 |
| Sullivan Christopher Ryan | ▲ Buy | Option Exercise | 2,876 | $28K | 8/17/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 37,945 | $753K | 8/17/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 3,749 | $75K | 8/17/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 1,000 | $13K | 8/17/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 1,000 | $20K | 8/17/2026 |
| Riley Jennifer | ▼ Sell | Open Market | 2,655 | $52K | 8/11/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 679 | $5K | 8/10/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 679 | $14K | 8/10/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 1,000 | $13K | 7/27/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 1,000 | $20K | 7/27/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 2,875 | $36K | 6/30/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 1,779 | $14K | 6/30/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 4,654 | $93K | 6/30/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 1,450 | $12K | 6/23/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 1,450 | $26K | 6/23/2026 |
| Riley Jennifer | ▼ Sell | Tax Withholding | 588 | $8K | 6/10/2026 |
| VARKI PAUL | ▼ Sell | Tax Withholding | 1,081 | $14K | 6/10/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Tax Withholding | 138 | $2K | 6/10/2026 |
| Doyle Mittie | ▼ Sell | Tax Withholding | 1,084 | $14K | 6/10/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 679 | $5K | 5/28/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 679 | $11K | 5/28/2026 |
| Riley Jennifer | ▲ Buy | Grant | 34,200 | $0 | 5/21/2026 |
| Sullivan Christopher Ryan | ▲ Buy | Grant | 39,900 | $0 | 5/21/2026 |
| VARKI PAUL | ▲ Buy | Grant | 24,300 | $0 | 5/21/2026 |
| Doyle Mittie | ▲ Buy | Grant | 43,500 | $0 | 5/21/2026 |
| NEIL GARRY ARTHUR | ▲ Buy | Grant | 100,200 | $0 | 5/21/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 3,000 | $38K | 5/15/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 3,000 | $56K | 5/15/2026 |
| Sullivan Christopher Ryan | ▲ Buy | Option Exercise | 18,606 | $184K | 5/7/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 18,606 | $449K | 5/7/2026 |
| VARKI PAUL | ▲ Buy | Option Exercise | 62,500 | $839K | 5/6/2026 |
| VARKI PAUL | ▲ Buy | Option Exercise | 12,563 | $101K | 5/6/2026 |
| VARKI PAUL | ▼ Sell | Open Market | 37,375 | $707K | 5/6/2026 |
| VARKI PAUL | ▼ Sell | Open Market | 5,196 | $103K | 5/6/2026 |
| VARKI PAUL | ▼ Sell | Open Market | 22,839 | $485K | 5/6/2026 |
| VARKI PAUL | ▼ Sell | Open Market | 9,253 | $210K | 5/6/2026 |
| VARKI PAUL | ▼ Sell | Open Market | 400 | $9K | 5/6/2026 |
| Sullivan Christopher Ryan | ▲ Buy | Option Exercise | 47,000 | $378K | 5/6/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 13,834 | $257K | 5/6/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 12,347 | $238K | 5/6/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 2,700 | $56K | 5/6/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 9,219 | $197K | 5/6/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 8,900 | $201K | 5/6/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 77,905 | $985K | 5/6/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 28,650 | $230K | 5/6/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 27,538 | $496K | 5/6/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 5,000 | $98K | 5/6/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 44,944 | $953K | 5/6/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 19,015 | $426K | 5/6/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 10,058 | $230K | 5/6/2026 |
| Mitchell Chan | ▼ Sell | Open Market | 3,167 | $72K | 5/6/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 1,000 | $13K | 5/5/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 679 | $5K | 5/5/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 1,679 | $27K | 5/5/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 8,457 | $112K | 4/30/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 8,458 | $111K | 4/29/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 3,970 | $50K | 4/6/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 3,970 | $72K | 4/6/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 1,780 | $31K | 4/2/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 6,200 | $106K | 4/2/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 500 | $8K | 4/1/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Open Market | 7,479 | $126K | 4/1/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 679 | $5K | 4/1/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 679 | $11K | 4/1/2026 |
| Truex Samantha | ▲ Buy | Option Exercise | 3,166 | — | 3/28/2026 |
| KANTOFF AARON | ▲ Buy | Option Exercise | 3,166 | — | 3/28/2026 |
| KAPLAN GILLA | ▲ Buy | Option Exercise | 3,166 | — | 3/28/2026 |
| NEIL GARRY ARTHUR | ▲ Buy | Option Exercise | 64,866 | — | 3/28/2026 |
| NEIL GARRY ARTHUR | ▼ Sell | Tax Withholding | 21,892 | $304K | 3/28/2026 |
| Sullivan Christopher Ryan | ▲ Buy | Option Exercise | 24,200 | — | 3/28/2026 |
| Sullivan Christopher Ryan | ▼ Sell | Tax Withholding | 8,241 | $114K | 3/28/2026 |
| Mitchell Chan | ▲ Buy | Option Exercise | 3,166 | — | 3/28/2026 |
| Goldman Jonathan | ▲ Buy | Option Exercise | 3,166 | — | 3/28/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 19,500 | $247K | 3/16/2026 |
| Doyle Mittie | ▲ Buy | Option Exercise | 5,992 | $48K | 3/16/2026 |
| Doyle Mittie | ▼ Sell | Open Market | 25,492 | $412K | 3/16/2026 |
| Doyle Mittie | ▼ Sell | Tax Withholding | 1,013 | $4K | 12/10/2025 |
| Riley Jennifer | ▼ Sell | Tax Withholding | 637 | $3K | 12/10/2025 |
| VARKI PAUL | ▼ Sell | Tax Withholding | 1,016 | $4K | 12/10/2025 |
| Sullivan Christopher Ryan | ▼ Sell | Tax Withholding | 155 | $636 | 12/10/2025 |
| Goldman Jonathan | ▼ Sell | Open Market | 3,167 | $45K | 11/14/2025 |
| Goldman Jonathan | ▲ Buy | Option Exercise | 8,200 | $81K | 11/14/2025 |
| Goldman Jonathan | ▼ Sell | Open Market | 8,200 | $118K | 11/14/2025 |
| Mitchell Chan | ▲ Buy | Option Exercise | 3,167 | — | 3/28/2025 |
| Goldman Jonathan | ▲ Buy | Option Exercise | 3,167 | — | 3/28/2025 |
| Truex Samantha | ▲ Buy | Option Exercise | 3,167 | — | 3/28/2025 |
| KANTOFF AARON | ▲ Buy | Option Exercise | 3,167 | — | 3/28/2025 |
| KAPLAN GILLA | ▲ Buy | Option Exercise | 3,167 | — | 3/28/2025 |
| Almenoff June Sherie | ▲ Buy | Option Exercise | 3,167 | — | 3/28/2025 |
| Sullivan Christopher Ryan | ▲ Buy | Option Exercise | 24,200 | — | 3/28/2025 |
| Sullivan Christopher Ryan | ▼ Sell | Tax Withholding | 7,285 | $62K | 3/28/2025 |
| NEIL GARRY ARTHUR | ▲ Buy | Option Exercise | 64,867 | — | 3/28/2025 |
| NEIL GARRY ARTHUR | ▼ Sell | Tax Withholding | 17,787 | $150K | 3/28/2025 |
| Almenoff June Sherie | ▲ Buy | Open Market | 500 | $7K | 11/13/2024 |
| Almenoff June Sherie | ▲ Buy | Open Market | 500 | $6K | 11/12/2024 |
| ARMISTICE CAPITAL, LLC | ▼ Sell | Open Market | 937,404 | $487K | 6/27/2023 |
| ARMISTICE CAPITAL, LLC | ▼ Sell | Open Market | 2,746,138 | $1.7M | 6/26/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 1,425,700 | $917K | 6/26/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 182,300 | $113K | 6/26/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 2,000 | $8K | 6/20/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 3,000 | $12K | 6/16/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 3,160 | $12K | 6/15/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 6,000 | $21K | 6/14/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 8,750 | $33K | 6/13/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 2,149 | $9K | 6/12/2023 |
| Sullivan Christopher Ryan | ▲ Buy | Open Market | 511 | $2K | 6/9/2023 |
| NEIL GARRY ARTHUR | ▲ Buy | Open Market | 4,000 | $14K | 6/9/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 5,044 | $21K | 6/9/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 6,398 | $25K | 6/8/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 2,984 | $10K | 6/7/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 844 | $2K | 5/31/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 671 | $2K | 5/30/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 2,000 | $6K | 5/25/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 3,481 | $10K | 5/24/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 5,519 | $16K | 5/24/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 7,000 | $23K | 5/22/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 6,500 | $23K | 5/19/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 13,121 | $43K | 5/18/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 379 | $1K | 5/16/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 1,715 | $4K | 5/15/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 2,285 | $6K | 5/12/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 5,000 | $13K | 5/8/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 5,000 | $14K | 5/5/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 15,000 | $42K | 5/4/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 1,504 | $4K | 4/27/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 425 | $1K | 4/26/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 5,571 | $17K | 4/25/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 12,500 | $38K | 4/24/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 5,000 | $15K | 4/20/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 10,000 | $29K | 4/18/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 15,000 | $44K | 4/17/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 25,000 | $71K | 4/11/2023 |
| Caissa Capital Management ltd. | ▲ Buy | Open Market | 31,329 | $71K | 4/10/2023 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 450,000 | — | 2/7/2023 |
| ARMISTICE CAPITAL, LLC | ▼ Sell | Other | 334 | $1K | 2/3/2023 |
| NEIL GARRY ARTHUR | ▲ Buy | Open Market | 2,083 | $9K | 12/9/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 100,000 | $65K | 3/14/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 100,000 | $69K | 3/11/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 26,000 | $18K | 3/10/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 325,000 | $213K | 3/7/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 135,000 | $95K | 3/4/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 50,000 | $36K | 3/3/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 40,000 | $32K | 2/25/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 100,000 | $80K | 2/24/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 83,000 | $64K | 2/22/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 55,000 | $45K | 2/18/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 150,000 | $122K | 2/17/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 12,000 | $10K | 1/20/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 93,700 | $82K | 1/19/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 206,300 | $182K | 1/18/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 85,000 | $79K | 1/14/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 312,700 | $314K | 1/13/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 57,300 | $60K | 1/12/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 16,003 | $15K | 1/11/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 491,097 | $485K | 1/10/2022 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 137,900 | $143K | 1/7/2022 |
| Wilkins H Jeffrey | ▲ Buy | Open Market | 6,371 | $10K | 12/10/2021 |
| Sullivan Christopher Ryan | ▲ Buy | Open Market | 955 | $1K | 12/10/2021 |
| Harrell James Archie Jr | ▲ Buy | Open Market | 1,093 | $2K | 12/10/2021 |
| NEIL GARRY ARTHUR | ▲ Buy | Open Market | 4,267 | $7K | 12/10/2021 |
| Greenway Schond L. | ▲ Buy | Open Market | 2,231 | $4K | 12/10/2021 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 5,454,545 | $12.0M | 9/17/2021 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 150,000 | $342K | 9/16/2021 |
| ARMISTICE CAPITAL, LLC | ▲ Buy | Open Market | 95,455 | $216K | 9/15/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Avalo Therapeutics Reports Phase 2 Progress on IL-1β Program
Avalo Therapeutics disclosed Phase 2 validation for its IL-1β franchise, a development that could expand the company's pipeline in inflammatory disease treatments. The biotech firm also announced inducement stock grants to new hires under Nasdaq listing rules and scheduled participation in investor conferences, routine corporate activities that signal active business expansion. The stock trades within its 52-week range, with the analyst consensus target notably above current levels.
Avalo Therapeutics Reports Phase 2 Progress on IL-1β Program. Avalo Therapeutics disclosed Phase 2 validation for its IL-1β franchise, a development that could expand the company's pipeline in inflammatory disease treatments. The biotech firm also announced inducement stock grants to new hires under Nasdaq listing rules and scheduled participation in investor conferences, routine corporate activities that signal active business expansion. The stock trades within its 52-week range, with the analyst consensus target notably above current levels.